Does CAPMATINIB Cause Dyspnoea? 141 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Dyspnoea have been filed in association with CAPMATINIB (TABRECTA). This represents 6.1% of all adverse event reports for CAPMATINIB.
141
Reports of Dyspnoea with CAPMATINIB
6.1%
of all CAPMATINIB reports
24
Deaths
51
Hospitalizations
How Dangerous Is Dyspnoea From CAPMATINIB?
Of the 141 reports, 24 (17.0%) resulted in death, 51 (36.2%) required hospitalization, and 5 (3.5%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPMATINIB. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Peripheral swelling (283)
Fatigue (257)
Oedema peripheral (247)
Nausea (240)
Malignant neoplasm progression (178)
Oedema (130)
Asthenia (113)
Non-small cell lung cancer (96)
Decreased appetite (95)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which CAPMATINIB Alternatives Have Lower Dyspnoea Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN